Whalatane
7 minutes ago
Icosapent ethyl (VAZKEPA®) was authorized by the HAS (Haute Autorité de Santé) on December 15th, 2021 in the following condition13, 14, 15: “Opinion in favor of reimbursement only in adult patients on treatment with a statin at the maximum tolerated dose, with very high CV risk due to established CV